TRDA Market Cap & Key Metrics
Entrada Therapeutics, Inc.
$4.55
-$0.31(-6.38%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$177.16M
Volume
740.06K
52W Range
$5.15 - $16.45
Target Price
$19.00
TRDA market cap is $177.16M. This page lists Entrada Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
TRDA Key Metrics
- Market cap
- $177.16M
- EPS estimate, current year
- $-4.03
- EPS growth, 3-year
- -4.74%
- Value score
- 60
- Quality score
- 34
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $25.42M | $210.78M | $129.01M | - | - |
| EBITDA | -$138.75M | $70.30M | $14.86M | -$95.35M | -$50.06M |
| EPS | $-3.47 | $1.76 | $-0.20 | $-3.02 | $-8.16 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRDA | $4.55 | -6.4% | 740.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Entrada Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW